Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trends and differences in tuberculosis incidences and clustering among natives in Denmark, Sweden and Finland: comparison of native incidences and molecular epidemiology among three low-incidence countries.
Pedersen MK, Lillebaek T, Andersen AB, Soini H, Haanperä M, Groenheit R, Jonsson J, Svensson E. Pedersen MK, et al. Among authors: groenheit r. Clin Microbiol Infect. 2018 Jul;24(7):717-723. doi: 10.1016/j.cmi.2017.10.005. Epub 2017 Oct 12. Clin Microbiol Infect. 2018. PMID: 29031789 Free article.
A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study.
Walker TM, Merker M, Knoblauch AM, Helbling P, Schoch OD, van der Werf MJ, Kranzer K, Fiebig L, Kröger S, Haas W, Hoffmann H, Indra A, Egli A, Cirillo DM, Robert J, Rogers TR, Groenheit R, Mengshoel AT, Mathys V, Haanperä M, Soolingen DV, Niemann S, Böttger EC, Keller PM; MDR-TB Cluster Consortium. Walker TM, et al. Among authors: groenheit r. Lancet Infect Dis. 2018 Apr;18(4):431-440. doi: 10.1016/S1473-3099(18)30004-5. Epub 2018 Jan 8. Lancet Infect Dis. 2018. PMID: 29326013 Free PMC article.
Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient.
Helbling P, Kröger S, Haas W, Brusin S, Cirillo DM, Groenheit R, Guthmann JP, Soini H, Hendrickx D, van der Werf MJ. Helbling P, et al. Among authors: groenheit r. Clin Microbiol Infect. 2018 Aug;24(8):918-919. doi: 10.1016/j.cmi.2018.03.015. Epub 2018 Mar 17. Clin Microbiol Infect. 2018. PMID: 29559390 Free PMC article. No abstract available.
Minimum Inhibitory Concentrations of Fluoroquinolones and Pyrazinamide Susceptibility Correlate to Clinical Improvement in Multidrug-resistant Tuberculosis Patients: A Nationwide Swedish Cohort Study Over 2 Decades.
Forsman LD, Jonsson J, Wagrell C, Werngren J, Mansjö M, Wijkander M, Groenheit R, Hammar U, Giske CG, Schön T, Bruchfeld J. Forsman LD, et al. Among authors: groenheit r. Clin Infect Dis. 2019 Sep 27;69(8):1394-1402. doi: 10.1093/cid/ciy1068. Clin Infect Dis. 2019. PMID: 30561569
Use of a whole genome sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017-2019: an ECDC pilot study.
Tagliani E, Anthony R, Kohl TA, de Neeling A, Nikolayevskyy V, Ködmön C, Maurer FP, Niemann S, van Soolingen D, van der Werf MJ, Cirillo DM; ECDC molecular surveillance project participants. Tagliani E, et al. Eur Respir J. 2021 Jan 5;57(1):2002272. doi: 10.1183/13993003.02272-2020. Print 2021 Jan. Eur Respir J. 2021. PMID: 32732329 Free PMC article.
Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis.
Kuhlin J, Davies Forsman L, Mansjö M, Jonsson Nordvall M, Wijkander M, Wagrell C, Jonsson J, Groenheit R, Werngren J, Schön T, Bruchfeld J. Kuhlin J, et al. Among authors: groenheit r. Clin Infect Dis. 2021 Nov 2;73(9):e3511-e3517. doi: 10.1093/cid/ciaa1509. Clin Infect Dis. 2021. PMID: 33011791
44 results